Active substance
SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR
Therapeutical formulation
TABLETTEN EN CAPSULES

€ 545.00 € 15,259.99 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Own risk

€ 545.00 € 15,259.99

This is the amount charged to your deductible per piece per package.

Strength
400/100/100MG
Supplier
ORIGINALIS B.V.
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
  • This drug is imported from {0).Ierland.
EU number
EU/1/17/1223/001